Concepedia

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial

Michael J. Seider, Stephanie L. Pugh, Corey J. Langer, Gwen Wyatt, William F. Demas, Afshin Rashtian, Cathy L. Clausen, Jerome Derdel, Sean Cleary, Christopher A. Peters,

Annals of Nuclear Medicine · 2018 · 13 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Chris Parker, Sten Nilsson, Daniel Heinrich et al. · New England Journal of Medicine · 2013 · 3.3K citations

, , +17

Mechanisms of Bone Metastasis

G. David Roodman · New England Journal of Medicine · 2004 · 2.7K citations

, , +12

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Alison Stopeck, Allan Lipton, Jean-Jacques Body et al. · Journal of Clinical Oncology · 2010 · 1.6K citations

, , +17

The clinical course of bone metastases from breast cancer

RE Coleman, RD Rubens · British Journal of Cancer · 1987 · 1.1K citations · Full text

, , +16

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 727 citations

, , +17